Acute glomerulonephritis by Dr.Fetiya.pptx

SantiyaSenti 93 views 82 slides Oct 19, 2024
Slide 1
Slide 1 of 82
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67
Slide 68
68
Slide 69
69
Slide 70
70
Slide 71
71
Slide 72
72
Slide 73
73
Slide 74
74
Slide 75
75
Slide 76
76
Slide 77
77
Slide 78
78
Slide 79
79
Slide 80
80
Slide 81
81
Slide 82
82

About This Presentation

External anatomy ; kidney is bean like structure that lies in the retroperitoneal space slightly above the level of the umbilicus. It is protected by 3 layers of capsules- renal capsule, perinephric fat capsule and renal fascia.
Internal anatomy; Outer layer, the cortex, contains the glomeruli, prox...


Slide Content

Acute Glomerulonephritis Apart From APSGN Presenter -Dr. F etiya M(year II resident) Moderator-Dr. Eyosiyat (assistant professor of pediatrics and child health) 11/12/2015 1

Outline Anatomy of kidney , glomerulus Definition and classification of glomerulonephritis Epidemiology of AGN . Presentation and management of specific types of glomerulonephritis Differential diagnostic algorithm of acute glomerulonephritis Summary Recommendation 11/12/2015 2

Objective Define , classify and differentiate among different types of glomerulonephritis Know how to approach to a patient with suspected glomerulonephritis Know how to manage acute glomerulonephritis 11/12/2015 3

Anatomy of the kidney , glomerulus External anatomy ; kidney is bean like structure that lies in the retroperitoneal space slightly above the level of the umbilicus. It is protected by 3 layers of capsules- renal capsule, perinephric fat capsule and renal fascia. Internal anatomy; Outer layer, the cortex, contains the glomeruli, proximal and distal convoluted tubules, and collecting ducts. Inner layer, the medulla, contains the straight portions of the tubules, the loops of Henle, the vasa recta, and the terminal collecting ducts . 11/12/2015 4

Cont.. 11/12/2015 5

Cont.. 11/12/2015 6

Definition Acute glomerulonephritis is an inflammatory process that involves glomerular tissue that can result in damage to the GBM, mesangium, epithelium or capillary endothelium . GN generally present as a constellation of findings that includes hematuria (GLOMERULAR) ,HTN ,renal dysfunction ,proteinuria and edema. 11/12/2015 7

Pathogenesis Glomerular injury may be a result of Genetic disorders, Immunologic disorders, Coagulation disorders or Perfusion disorders. 8 11/12/2015

Cont.. Genetic disorders Mutations of genes encoding proteins located within the Glomerulus, interstitium, or tubular epithelium. Most of these defects are within the podocytes . 9 11/12/2015

CONT.. Immunologic injury:- Immunologic injury to the glomerulus results in glomerulonephritis, which is a generic term for several diseases, but more precisely a histopathologic term defining inflammation of the glomerular capillaries . 11/12/2015 10

Cont.. Two major mechanisms: 1. Deposition of antigen-antibody immune complexes - in situ binding of antibodies to antigens localized within the glomeruli. The antigen can be structural glomeruli components,Alternatively , the antigens may be trapped or deposited within the glomerulus - deposition of circulating antigen antibody immune complexes 2 . Cellular mediated 11/12/2015 11

Cont.. Coagulation system Directly after endothelial cell injury or Indirectly after Complement activation Hypo perfusion renal h ypo perfusion causes ATN and collapse of glomerular tuft. 11/12/2015 12

Classification of glomerulonephritis Classification of glomerulonephritis is based on Clinical presentation Etiology Histopathology 11/12/2015 13

Clinical presentation Acute GN Rapidly progressive GN Recurrent macroscopic hematuria Chronic GN. 11/12/2015 14

Etiologic Classification Primary glomerulonephritis Membranoproliferative glomerulonephritis Membranous glomerulonephritis IgA nephropathy Idiopathic crescentic glomerulonephritis APSGN 11/12/2015 15

Cont.. Secondary glomerulonephritis Systemic lupus erythematosus nephritis Other post-infectious glomerulonephritis Henoch- Schönlein purpura nephritis Anti-glomerular basement membrane disease Microscopic polyangiitis Wegener granulomatosus 11/12/2015 16

Classification based on Histopathology 11/12/2015 17

Epidemiology The most common worldwide cause of glomerulonephritis is IGA nephropathy In developing countries ,it rankes 1 st or 2 nd cause of ckd in developed it is 3 rd cause ,over all GN is the second commonest cause of ckd world wide 25%. 11/12/2015 18

Cont.. Renal disease pattern among Niger children in 2 hospitals ,renal disease account for 1.6% of all admission ,acute GN Account 1.8%. Renal disease 3.3% admission in black lion ,among them 12.2 % acute glomerulonephritis . 11/12/2015 19

Presentation and management of specific types of glomerulonephritis 11/12/2015 20

Rapidly progressive GN A clinical course of several forms of glomerulonephritis that have the unifying feature of a histopathologic finding of crescents in the majority of glomeruli . A sub-group of patients with acute GN designated as “rapidly progressive GN” [RPGN] Which have A n aggressive clinical presentation , progressive decline of renal function occurring over days to weeks and presence of crescents around the glomerular tufts in renal biopsy 11/12/2015 21

Cont.. 11/12/2015 22

Cont.. Patients with systemic vasculitis appear to be particularly prone to develop CGN. Patients with Henoch- Schönlein purpura (HSP), Anti neutrophil cytoplasmic antibody (ANCA-mediated GN (microscopic polyangiitis and granulomatosis with poly angiitis ), and systemic lupus erythematosus account for the majority of patients with CGN 11/12/2015 23

Cont.. Post infectious GN or endocarditis rarely progresses to CGN, but because it is the most common form of GN in childhood it accounts for a significant percentage of patients with CGN in most reports. If no underlying cause is identified by systemic features, serologic testing, or histologic examination, the disease is classified as idiopathic CGN. 11/12/2015 24

Types of RPGN Based on histological classification Type I: Anti–glomerular basement membrane antibody disease Type II: Immune complex mediated Type III: Pauci -immune (usually antineutrophil cytoplasmic antibody–positive) 11/12/2015 25

Clinical Manifestations Most children present with acute nephritis (hematuria, various degrees of renal dysfunction, and hypertension) and usually have concomitant proteinuria, often with nephrotic syndrome. Occasional patients present late in the course of disease with oliguric renal failure 11/12/2015 26

Diagnosis The diagnosis of CGN is made by obtaining a kidney biopsy Delineation of the underlying etiology is reached by a combination of additional biopsy findings , extrarenal symptoms and signs, and serologic testing . 11/12/2015 27

Prognosis and Treatment progression to end-stage renal disease within weeks to months from the onset is common combination of high-dose corticosteroids and cyclophosphamide may be effective in preventing progressive renal failure in patients with systemic lupus erythematosus, HSP nephritis, granulomatosis with polyangiitis , and IgA nephropathy if given early in the course 11/12/2015 28

Cont.. combination with immunosuppression, plasmapheresis has been reported to benefit patients with Goodpasture disease. Plasmapheresis may also benefit patients with ANCA associated CGN, in particular those with the most severe renal dysfunction and pulmonary hemorrhage at presentation 11/12/2015 29

Membranoproliferative Glomerulonephritis ( MPGN) MPGN is sometimes called mesangiocapillary glomerulonephritis or lobar glomerulonephritis. most commonly occurs in older children or young adults. 30 11/12/2015

Etiologic Classification primary (idiopathic) Secondary forms of glomerular disease. Infection Rheumatologic disease Malignancy Inherited disorder 31 11/12/2015

Clinical Manifestations and Evaluation Most common in second decade of life Nephrotic syndrome Acute nephritic syndrome, RPGN Persistent asymptomatic microscopic hematuria and proteinuria Serum C3 complement levels are low in majority of cases 32 11/12/2015

Investigation U/A RFT, electrolyte Complement level Test for underlying secondary cause Renal biopsy 11/12/2015 33

Cont.. The diagnosis of MPGN is made by renal biopsy. Indications for biopsy include nephrotic syndrome in an older child , significant proteinuria with microscopic hematuria, and hypocomplementemia lasting > 2 mo in a child with acute nephritis 11/12/2015 34

Histlogical classification Immunoflourescence based classification Immune complex mediated Complement mediated 35 11/12/2015

CONT.. Electron microscope based classification  MPGN I- sub-endothelial deposit MPGN II- dense like deposit along GBM, tubules and bowmans capsule MPGN III- similar to MPGN I but has sub-epithelial deposit. 36 11/12/2015

11/12/2015 37

Treatment No defintive therapy exists for MPGN Management has 3 components Treatment of underlying cause Assessing the prognosis of the patient Poor prognosis-Untreated primary MPGN(ESRD 50% by 10yr and 100% by 20yr), 38 11/12/2015

Cont.. Those with Nephrotic symptoms , increased creatinine , hypertension, presentation progress to renal failure more rapidly 3. Treatment of glomerulonephritis ACEI, ARB Glucocorticoid Eculizumab (anti–C5 antibody ) Renal transplant. 11/12/2015 39

IgA Nephropathy It is the most common chronic glomerulonephritis in children and adolescents with microscopic hematuria(35%) and non nephrotic proteinuria(30%) There is male preponderance commonly in the second and third decade of life 11/12/2015 40

Pathogenesis Excessive amount of poorly glycosylated IgA1 in the serum → production of IgG and IgA autoantibodies → immune complex → deposit in the mesangium → mesangeal proliferation The IgA deposit is also accompanied by C3 deposit 11/12/2015 41

Pathology Focal and segmental proliferation Epithelial cell crescent formation Glomerular fibrosis and sclerosis Tubulointerstitial fibrosis or sclerosis IgA and C3 complement deposition 11/12/2015 42

Clinical features Recurrent gross hematuria Occurs 1-2days after upper respiratory tract or gastrointestinal infections Asymptomatic microscopic hematuria and proteinuria Acute nephritic syndrome is very rare 11/12/2015 43

Investigations Serum IgA leve l Serum C3 is normal ASO titer Renal function test Serum protein 11/12/2015 44

Cont.. Urine protein to creatinine ratio( Upr:Ucr ) Renal biopsy 11/12/2015 45

11/12/2015 46

11/12/2015 47

Cont.. Other treatment modalities Tonsillectomy Long term antibiotics Gluten free diet Fish oil/omega 3 fatty acid preparation (we don't have in Ethiopia) 11/12/2015 48

Anti glomerular Basement Membrane Disease ( Anti-GBM Disease) Caused by auto antibodies against alveolar and glomurular basement membrane When there is pulmonary hemorrhage, glomerulonephritis and anti GBM antibody it is referred to as Goodpasture's syndrome. Causes RPGN. 49 11/12/2015

Clinical Manifestations Good pasture disease is rare in childhood. Hematuria , hypertension and rapid deterioration of RFT Pulmonary manifestation- cough, SOB, hemoptysis Iron deficiency anemia for those with prolonged bleeding Less commonly, patients can have isolated anti-GBM nephritis 50 11/12/2015

Pathology Kidney biopsy shows crescentic glomerulonephritis in most patients. Immunofluorescence microscopy demonstrates the pathognomonic continuous linear deposition of immunoglobulin G along the GBM 11/12/2015 51

11/12/2015 52

Treatment Plasmapheresis combined with  high-dose intravenous methylprednisolone  and  cyclophosphamide. This should be followed by po prednisolone and cyclophosphamide until remission is achieved and then prednisolone / azathioprine for 6-9mos Duration of therapy Unknown and depends on remission. 53 11/12/2015

Prognosis Untreated, the prognosis of Good pasture disease is poor. Risk of ESRD is above 90% Poor prognosis High cr upon presentation, need for dialysis and crescent formation Patients with isolated nephritis have better prognosis . 11/12/2015 54

Lupus Nephritis Common and serious complication of SLE. Although SLE is less frequent in children, renal involvement is more common(80%) and is more severe than that seen in adults. Most important cause of morbidity and mortality in SLE. 55 11/12/2015

Pathogenesis Lupus nephritis is primarily due to anti dsDNA Ab Forms immune complexes with DNA, GBM and mesangium , sub endothelial , and/or sub epithelial compartments of the glomerulus This leads to complement activation. 56 11/12/2015

Clinical manifestation 11/12/2015 57

Histologic classification 11/12/2015 58

Diagnosis The diagnosis of SLE is confirmed by the detection of antinuclear antibodies (ANA) and anti-ds DNA ) Low C3 and C4 Renal biopsy Should be performed in all patients with SLE who display even minor urinary abnormalities 11/12/2015 59

11/12/2015 60

Treatment There are no randomized controlled trials to indicate the optimal treatment of lupus nephritis in children. Current therapies are largely based on the histology, clinical severity, and lessons learned from clinical trials of adults with lupus nephritis. Immunosuppression remains the cornerstone of therapy. 11/12/2015 61

Treatment Therapy is initiated in all patients with prednisone at a dose of 1-2 mg/kg/day in divided doses, followed by a slow steroid taper over 4-6 mo beginning 4-6 wk after serologic remission is achieved For class III and IV Combination of high-dose steroids with either cyclophosphamide or mycophenolate 11/12/2015 62

Cont.. For class V lupus nephritis treatment remains unclear. low risk of progression to end-stage renal disease encouraged a less aggressive approach on one hand uncontrolled nephrotic syndrome require more aggressive immunosuppression on the other For Class VI no treatment prevents renal failure 63 11/12/2015

Prognosis Overall, renal survival( CKD without the need for end-stage renal disease therapys) is seen in 80% of patients 10 yr after the diagnosis of SLE nephritis. Poor prognostic factors for ESRD diffuse proliferative WHO class IV lupus nephritis , poor renal function at presentation, or persistent nephrotic -range proteinuria . 64 11/12/2015

Henoch- Schönlein Purpura ( IgA vasculitis) Is an idiopathic systemic immune complex–mediated vasculitis associated with IgA deposition within small-vessel walls. The most common small vessel vasculitis in children. Peak incidence in early childhood (4-6 yr of age). 90% of cases occur in children. 65 11/12/2015

Pathogenesis Similar to IgA nephropathy Mediated by the deposition of polymeric immunoglobulin A (IgA) in glomeruli . IgA immune complexes are deposited throughout the body and activate pathways leading to necrotizing vasculitis .primarily those of the skin and intestine. 66 11/12/2015

Clinical Manifestations The classic tetrad of HSP Palpable purpura, Arthralgia, Abdominal pain, and Renal disease . 67 11/12/2015

11/12/2015 68

Cont.. Renal manifestation Occurs ~ 50% of patients with HSP. ~ 80% initially microscopic hematuria and proteinuria The remaning present as nephrotic -nephritic syndrome Older children(and adults) have a greater risk for more severe involvement. 69 11/12/2015

Investigation CBC- leukocytosis , normal/ thrombocytosis , mild anemia, Elevated ESR and CRP. Stool exam Albumin level 11/12/2015 70

Cont.. Urinalysis and serum creatinine Renal biopsy- significant proteinuria, significant hypertension, or elevated serum creatinine. Serum IgA levels have been reported to be elevated in 50 to 70 percent of patients with IgAV 11/12/2015 71

11/12/2015 72

Treatment No convincing randomized clinical studies or evidence-based guidelines exist Mild HSP nephritis-does not require treatment, because it usually resolves spontaneously . 11/12/2015 73

Cont.. For moderate or severe HSP nephritis high-dose and extended courses of corticosteroids with azathioprine, mycophenolate mofetil, or cyclophosphamide 11/12/2015 74

Prognosis and Treatment The prognosis of HSP nephritis for most patients is excellent. Untreated, the risk of developing chronic kidney disease, including ESRD, is 2–5% in all patients with HSP 50% in those with the most severe early renal clinical and histologic features. 75 11/12/2015

Differential diagnostic algorithm of acute glomerulonephritis 11/12/2015 76

11/12/2015 77

Summary Glomerulonephritis refers to an inflammatory process that involves glomerular tissue. One of the causes significant suffering in children Manifestation, management and prognosis varies according to underlying etiology Renal biopsy is needed to make the diagnosis as well as for prognostic purpose 11/12/2015 78

Recommendation Careful evaluation of any patient with clinical renal or urinary sediment abnormality The hospital needs nephrology unit and pediatric nephrologist Necessary investigations should always be available Timely referral of the patient who need nephrologist evaluation 11/12/2015 79

Reference's Nelson text book of pediatrics 21 st ed. Uptodate 2023 Comprehensive pediatric nephrology,chapter 11, nephritic syndrome Pattern and outcome of renal disease in hospitalized children in BLH ,Addis Ababa ,Ethiopia, Dr. damte shimels and kebede mola ,2016 11/12 / 2015 80

Acute Glomerular Diseases in Children, The Open Urology & Nephrology Journal, Kanwal K. Kher,2015 . Hand book on the manegment of pediatric renal problems in Ethiopia ,march 2009 AGN in children of the Niger delta region , Nigeria , gi mcgil ugwu ,2015 11/12/2015 81

THANK YOU 11/12/2015 82